Company Information

Andrew Heath MD

Andrew has broad experience of European and US healthcare, with an in-depth knowledge of the US and UK capital markets in life sciences. After an early career in academic and clinical medicine in Sweden and at Vanderbilt University in Nashville,TN, Dr Heath held senior research positions with Glaxo, Sweden, and Astra AB. Returning to the US with Astra USA, he was Vice President, Marketing and Sales, before joining Aerogen, Inc as President and CEO. He was Chief Executive Officer of Protherics plc from 1998 to 2008, taking the company from 30 to 350 staff and managing its eventual acquisition by BTG for £220 million.  He is currently a non-executive director of Oxford BioMedica plc, XL TechGroup Inc, Anew Inc, Pioneer Technology Inc, and is a director of the BioIndustry Association.

Back

Board of Directors | Senior Management